The latest trading day saw Medtronic (MDT) settling at $87.72, representing a -0.45% change from its previous close.
Like its peers, the impact of the present geopolitical situation may have curbed fiscal second-quarter profits for Medtronic.
These are the kinds of stocks that can allow investors to sleep easy at night.
Medtronic (MDT) reachead $90.07 at the closing of the latest trading day, reflecting a +0.92% change compared to its last close.
In the most recent trading session, Medtronic (MDT) closed at $90.60, indicating a +0.01% shift from the previous trading day.
Medtronic (MDT) closed the most recent trading day at $91.12, moving +0.1% from the previous trading session.
Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or Abbott (ABT). But which of these two companies is the best option for those looking for undervalued stocks?
In the latest trading session, Medtronic (MDT) closed at $89.36, marking a +0.57% move from the previous day.
Medtronic remains an attractive investment due to its diversified revenue streams, robust product pipeline and improving margins. MDT's growth is driven by strong performance in Neuroscience, Cardiovascular, and Diabetes care, with significant international revenue growth and a promising product pipeline. Trading below its historical valuation, MDT offers a compelling opportunity for conservative investors seeking quality at a reasonably low price.
The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.
JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.
Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.